FMR CORP 13D/13G Filings for Alto Neuroscience, Inc. (ANRO)

FMR CORP 13D and 13G filings for Alto Neuroscience, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-12
09:16 am
Sale		 2024-12-31 13G Alto Neuroscience, Inc.
ANRO		 FMR CORP 1,265,546
4.700%		 -1,097,510decrease
(-46.44%)		 Filing
2024-11-12
09:50 am
Purchase		 2024-11-08 13G Alto Neuroscience, Inc.
ANRO		 FMR CORP 2,363,056
8.765%		 2,363,056increase
(New Position)		 Filing